Virbac Beheer

Beheer criteriumcontroles 4/4

De CEO Virbac is Habib Ramdani, benoemd in Jun2016, heeft een ambtstermijn van 8.42 jaar. De totale jaarlijkse vergoeding van { bedraagt € 442.92K, bestaande uit 55.3% salaris en 44.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.014% van de aandelen van het bedrijf, ter waarde € 418.23K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.7 jaar en 3.9 jaar.

Belangrijke informatie

Habib Ramdani

Algemeen directeur

€442.9k

Totale compensatie

Percentage CEO-salaris	55.3%
Dienstverband CEO	8.4yrs
Eigendom CEO	0.01%
Management gemiddelde ambtstermijn	3.7yrs
Gemiddelde ambtstermijn bestuur	3.9yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Habib Ramdani's beloning veranderd ten opzichte van Virbac's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	€141m
Mar 31 2024	n/a	n/a	€131m
Dec 31 2023	€443k	€245k	€121m
Sep 30 2023	n/a	n/a	€120m
Jun 30 2023	n/a	n/a	€119m
Mar 31 2023	n/a	n/a	€121m
Dec 31 2022	€395k	€233k	€122m
Sep 30 2022	n/a	n/a	€120m
Jun 30 2022	n/a	n/a	€119m
Mar 31 2022	n/a	n/a	€116m
Dec 31 2021	€458k	€227k	€113m
Sep 30 2021	n/a	n/a	€137m
Jun 30 2021	n/a	n/a	€161m
Mar 31 2021	n/a	n/a	€148m
Dec 31 2020	€311k	€222k	€136m
Sep 30 2020	n/a	n/a	€104m
Jun 30 2020	n/a	n/a	€72m
Mar 31 2020	n/a	n/a	€62m
Dec 31 2019	€299k	€213k	€52m
Sep 30 2019	n/a	n/a	€43m
Jun 30 2019	n/a	n/a	€34m
Mar 31 2019	n/a	n/a	€27m
Dec 31 2018	€400k	€203k	€20m
Sep 30 2018	n/a	n/a	€8m
Jun 30 2018	n/a	n/a	-€4m
Mar 31 2018	n/a	n/a	-€3m
Dec 31 2017	€212k	€203k	-€3m

Compensatie versus markt: De totale vergoeding ($USD 475.44K ) Habib } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 3.03M ).

Compensatie versus inkomsten: De vergoeding van Habib is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Habib Ramdani (48 yo)

8.4yrs

Tenure

€442,921

Compensatie

Mr. Habib Ramdani servesa s Interim CEO of Virbac SA from July 2024. He has been Chief Financial Officer at Virbac SA since June 30, 2016 and serves as its Deputy Chief Executive Officer since December 15,...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Habib Ramdani	Interim CEO & CFO	8.4yrs	€442.92k	0.014% € 418.2k
Marc Bistuer	Deputy CEO and Head of Compliance & Corporate Quality Assurance	1.8yrs	€396.22k	0.088% € 2.6m
Sandrine Brunel	Head of Corporate Communications	no data	geen gegevens	geen gegevens
Nathalie Pollet	Head of Global Marketing & Market Development	3.8yrs	geen gegevens	geen gegevens
Francesca Cortella	Head of Corporate Human Resources	9.8yrs	geen gegevens	geen gegevens
Sophie Favini	Head of Global Business Operations	2.8yrs	geen gegevens	geen gegevens
Bertrand Havrileck	Head of Corporate R&D	3.6yrs	geen gegevens	geen gegevens
André Mathieu	Head of Global Industrial Operations	no data	geen gegevens	geen gegevens
Manuela Rodríguez	Director of Financial Projects	no data	geen gegevens	geen gegevens

3.7yrs

Gemiddelde duur

Ervaren management: Het managementteam van 0NM7 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Pierre Madelpuech	Vice Chairman of the Board of Directors	3.9yrs	€27.00k	0.0013% € 38.2k
Marie-Helene Dick-Madelpuech	Chairwoman of Board of Directors	3.9yrs	€137.00k	50.19% € 1.5b
Xavier Yon	Non-Voting Advisor	no data	€24.00k	geen gegevens
Olivier Charmeil	Independent Director	less than a year	geen gegevens	0.00012% € 3.5k
Philippe Gaston Capron	Member of Board of Directors	3.9yrs	€30.00k	0.0053% € 154.1k
Cyrille Petit	Independent Member of Board of Directors	3.9yrs	€27.00k	0.0031% € 90.5k
Solene Madelpuech	Members of the Board of Directors	3.9yrs	€27.00k	0.00012% € 3.5k
Sylvie Gueguen	Employee Representative Director	3.9yrs	geen gegevens	0.0016% € 48.2k
Rodolphe Durand	Non-Voting Advisor	no data	€24.00k	geen gegevens

3.9yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 0NM7 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.9 jaar).

Virbac Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Virbac Sa Announces Chief Executive Officer Changes

Virbac SA, Annual General Meeting, Jun 21, 2021

Recent updates

Virbac SA Revises Earnings Guidance for the Fiscal Year 2024

Virbac Sa Announces Chief Executive Officer Changes

Upcoming dividend of €1.32 per share

Upcoming dividend of €1.32 per share

Upcoming dividend of €1.32 per share

Dividend of €1.32 announced

Full year 2023 earnings released: EPS: €14.40 (vs €14.43 in FY 2022)

Virbac SA (ENXTPA:VIRP) acquired Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591).

Full year 2023 earnings released: EPS: €14.40 (vs €14.44 in FY 2022)

Virbac SA (ENXTPA:VIRP) entered into a definitive agreement to acquire Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591) for an enterprise value of approximately €280 million.

Virbac SA Provides Earnings Guidance for the Year 2024

Now 20% undervalued

Virbac SA to Report Fiscal Year 2023 Results on Mar 19, 2024

Investor sentiment improves as stock rises 19%

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.

First half 2023 earnings released: EPS: €8.86 (vs €9.18 in 1H 2022)

Virbac SA Confirms Revenue Forecasts for the Year 2023

Upcoming dividend of €1.32 per share at 0.5% yield

Full year 2022 earnings released: EPS: €14.44 (vs €13.40 in FY 2021)

Virbac SA to Report First Half, 2023 Results on Sep 14, 2023

Virbac SA to Report Fiscal Year 2022 Results on Mar 23, 2023

Investor sentiment deteriorated over the past week

Virbac SA Provides Revenue Guidance for the Year 2022

First half 2022 earnings released: EPS: €9.18 (vs €8.54 in 1H 2021)

Investor sentiment deteriorated over the past week

Upcoming dividend of €1.25 per share

Full year 2021 earnings released: EPS: €13.40 (vs €16.13 in FY 2020)

Virbac SA Provides Revenue Guidance for the Year 2022

Virbac SA (ENXTPA:VIRP) acquired an additional 15% stake in Centrovet group for $17.7 million.

Virbac SA Raises Revenue Guidance for 2021

Upcoming dividend of €0.75 per share

Friulchem S.p.A. (BIT:FCM) signed a preliminary agreement to acquire Business Unit of Virbac SA (ENXTPA:VIRP) for €2.5 million.

Investor sentiment improved over the past week

Virbac SA Revises Earnings Guidance for the Year 2021

Full year 2020 earnings released: EPS €16.29 (vs €6.11 in FY 2019)

Virbac SA Proposes Dividend for the 2020 Financial Year

Virbac SA to Report Fiscal Year 2020 Results on Mar 17, 2021

New 90-day low: €202

Algenex and Virbac Signs International Commercial Licensing Agreement for Crisbio-Based Vaccine in Major Swine Indication

Investor sentiment deteriorated over the past week

New 90-day high: €244

Virbac SA, Annual General Meeting, Jun 21, 2021

New 90-day high: €233

New 90-day high: €223

New 90-day high: €206

First half earnings released

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd